Anthrax Toxin Receptor 1/Tumor Endothelial Marker 8: Mutation of Conserved Inserted Domain Residues Overrides Cytosolic Control of Protective Antigen Binding

作者：Ramey Jordan D; Villareal Valerie A; Ng Charles; Ward Sabrina C; Xiong Jian Ping; Clubb Robert T; Bradley Kenneth A^*

来源：Biochemistry, 2010, 49(34): 7403-7410.

DOI：10.1021/bi100887w

Anthrax toxin receptor I (ANTX RI)/tumor endothelial marker 8 (TEM 8) is one of two known proteinaceous cell surface anthrax toxin receptors. A metal ion dependent adhesion site (MIDAS) present in the integrin-like inserted (I) domain of ANTXRI mediates the binding of the anthrax toxin subunit, protective antigen (PA). Here we provide evidence that single point mutations in the 1 domain can override regulation of ANTX RI ligand-binding activity mediated by intracellular signals. A previously reported MIDAS mutant of ANTXRI (T118A) was found to retain normal metal ion binding and secondary structure but failed to bind PA, consistent with a locked inactive state. Conversely, mutation of a conserved I domain phenylalanine residue to a tryptophan (F205W) increased the proportion of cell-surface ANTX RI that bound PA, consistent with a locked active state. Interestingly, the K(D) and total amount of PA bound by the isolated ANTXRI I domain were not affected by the F205W mutation, indicating that ANTXRI is preferentially found in the active state in the absence of inside-out signaling. Circular dichroism (CD) spectroscopy and (1)H-(15)N heteronuclear single-quantum coherence (HSQC) nuclear magnetic resonance (NMR) revealed that structural changes between T118A, F205W, and WT I domains were minor despite a greater than 10(3)-fold difference in their abilities to bind toxin. Regulation of toxin binding has important implications for the design of toxin inhibitors and for the targeting of ANTXRI for antitumor therapies.

• 出版日期2010-8-31